3-(4-Chloro-phenyl)-3-oxo-propionic acid ethyl ester, 95.0%, 100g

METHYL (2R)-2-AMINO-2-(4-BROMOPHENYL)ACETATE HCL, 95.0%, 5g

5-Bromonaphtho[1,2-d][1,2,3]oxadiazole, 98%, 500mg

1,8-Naphthyridine, 98.0%, 25g

1,1-Dimethyl-3-[3-(trifluoromethyl)phenyl]urea>97.0%(N)5g

Bromo-PEG1-C2-Boc, 98.58%, 100mg

Ethyl 7-fluoro-4-methoxy-1H-indole-2-carboxylate, 97.0%, 10g

methyl (S)-(1-((4-(3-iodo-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate, 97%, 50mg

3-Bromo-1H-pyrrolo[2,3-b]pyridine, 95.0%, 1g

5-Nitro-1H-benzimidazol-3-ium Trifluoromethanesulfonate>98.0%(HPLC)(T)10g

4-[(6-Methoxy-2-methylsulfanyl-pyrimidin-4-ylamino)-methyl]-piperidine-1-carboxylic acid tert-butyl ester, 95.0%, 250mg

GC capillary column ROTI®Cap-XLB, 30 m, 1 Piece(s)

(2-Amino-4-(trifluoromethyl)thiazol-5-yl)methanol, 95.0%, 250mg